论文信息 - Phase II study of nimotuzumab, a humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody, in patients with locally advanced or metastatic pancreatic cancer - 字舞流文

Phase II study of nimotuzumab, a humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody, in patients with locally advanced or metastatic pancreatic cancer

F. Lordick | D. Strumberg | R. Hilger | M. Scheulen | L. Edler | J. Krauss | D. Reuter | K. Mross | B. Schultheis | F. Bach | N. Marschner | Max E. Scheulen | Jürgen Krauss | Norbert Marschner | Lutz Edler | M. E. Scheulen | Norbert Marschner